The higher suppressive impact of vantictumab or ipafricept over solo anti-PD-1 is reported in animal tumor model of melanoma, which is correlated with higher intra-tumoral infiltration of tumor-specific CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.